The invention relates to a set of isolated marker genes comprising at least one gene identified as having differential expression as between patients who are responders and non responders to an erbB receptor tyrosine kinase inhibitor; said gene set comprising one or more genes selected from at least the group consisting of the (51) genes listed herein including gene-specific oligonucleotides derived from said genes; and uses of sauch sets in diagnostic applications.

Title
Process
Application Number
EP20040735607 20040601
Publication Number
1633870 (A1)
Application Date
June 1, 2004
Publication Date
March 15, 2006
Inventor
Fukuoka Masahiro
JP
Sone Saburo
JP
Nakamura Yusuke
JP
Tsuruo Takashi
JP
Assignee
Univ Tokyo
JP
Astrazeneca
GB
IPC
C12Q 01/68
C12N 15/11
C12Q 01/68
C07K 14/435
C12Q 01/68
C07K 14/47
View Original Source Download PDF